- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
4E-BP1 AntibodyRabbit Monoclonal Antibody
| Country | United States
Ordering Information
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others 
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AJ1004a | 100ul 400 ul | 2-3 days | $ 315.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
4E-BP1 Antibody - Product info | |
| Application | WB, IHC
|
| Primary Accession | Q13541 |
| Reactivity | Human, Mouse, Rat |
| Clone Names | Y329 |
| Calculated MW | 12580 Da |
| Gene ID 1978 | |
| Other Names EIF4EBP1, Eukaryotic translation initiation factor 4E-binding protein 1, Phosphorylated heat- and acid-stable protein regulated by insulin 1 | |
| Target/Specificity A synthetic peptide corresponding to residues near the N-term of human4E-BP1 was used as immunogen. | |
| Dilution WB~~1:2000~10000 IHC~~1:100~250 | |
| Format 50 mM Tris-Glycine (pH 7.4), 0.15 M NaCl, 40% Glycerol, 0.01% sodium azide and 0.05% BSA. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions 4E-BP1 Antibody is for research use only and not for use in diagnostic or therapeutic procedures. | |
4E-BP1 Antibody - Protein Information | |
| Name EIF4EBP1 | |
| Function Regulates eIF4E activity by preventing its assembly into the eIF4F complex. Mediates the regulation of protein translation by hormones, growth factors and other stimuli that signal through the MAP kinase and mTORC1 pathways | |
4E-BP1 Antibody - Related products
AP12627c: EIF4EBP1 Antibody (Center)
AP1981a: EIF4EBP1 Antibody (S100)
AP1981b: EIF4EBP1 Antibody (T36)
AP1981c: EIF4EBP1 Antibody (T69)
AP1981d: EIF4EBP1 Antibody(S111)
AP3353a: Phospho-EIF4EBP1-pS100 Antibody
AP3417a: Phospho-EIF4EBP1-pT36 Antibody
AP3473a: Phospho-EIF4EBP1-S111 Antibody
RI11733: EIF4EBP1 predesign siRNA
LY10995a: EIF4EBP1 Over-expression Lysate
BP1981a: EIF4EBP1 Antibody (S100) Blocking Peptide
BP1981b: EIF4EBP1 Antibody (T36) Blocking Peptide
BP1981c: EIF4EBP1 Antibody (T69) Blocking Peptide
BP3417a: Phospho-EIF4EBP1-pT36 Antibody Blocking Peptide
BP3473a: Phospho-EIF4EBP1-S111 Antibody Blocking Peptide
AJ1004d: 4E-BP1 Antibody Phospho (pT37)
AJ1004e: 4E-BP1 Antibody Phospho (pT70)
AJ1004f: 4E-BP1/2/3 Antibody Phospho (pT45)
4E-BP1 Antibody - Application data
-
A. Western blot analysis on 293 cell lysate using anti-4E-BP1 RabMAb (Cat. #AJ1004a), dilution 1:10,000.
-
B. Immunohistochemical analysis of paraffin-embedded human colon carcinoma using anti-4E-BP1 RabMAb (Cat. #AJ1004a).
4E-BP1 Antibody - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
4E-BP1 (eIF4E-binding protein) also known as PHAS, is a 10-12 kDa acidic protein that compete with eIF4G for binding of eiF4E to the mRNA 5 cap structure (1). Binding of the 4E-BPs to eIF4E is reversible and is dependent on the phosphorylation status of 4E-BP. Non-phosphorylated 4E-BP1 will bind strongly to eiF4E while, the phosphorylated form will no (2)t. Akt, TOR, MAP kinase, S6 kinase, and Cdc2 are known kinases capable of inactivating 4E-BP1 binding to eIF4E by phosphorylating either threonines 35, 45, 69 or serine 64. Although, not all phosphorylation events equally block the 4EBP1-eIF4E interaction (3-4)
REFERENCES
1. Pause, A., G.J. Belsham, A.-C. Gingras, O. Donz
2. Gingras, A.-C., S.G. Kennedy, M.A. O'Leary, N. Sonenberg, and N. Hay. 1998. Genes & Dev. 12: 502-513
3. Iritani, B. M., and Eisenman, R. N. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 13180
4. Trumpp, A., Refaeli, Y., Oskarsson, T., Gasser, S., Murphy, M., Martin, G. R., and Bishop, J. M. (2001) Nature 414, 768
